Morgan Stanley Reiterates Underweight, $24 Target On Keurig Dr. Pepper As Firm Believes 'the market is overestimating KDP's LT growth potential, with limited revenue growth and EBITDA margin expansion after synergy-related growth dissipates'

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!